191 related articles for article (PubMed ID: 9052513)
1. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats.
Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K
Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
Murakami K; Okajima K; Harada N; Isobe H; Okabe H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
[TBL] [Abstract][Full Text] [Related]
3. Role of granulocyte elastase in indomethacin-induced gastric mucosal lesion formation in rats.
Murakami K; Okajima K; Uchiba M; Harada N; Liu W; Okabe H; Takatsuki K
J Lab Clin Med; 1997 Sep; 130(3):307-13. PubMed ID: 9341991
[TBL] [Abstract][Full Text] [Related]
4. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide decreases the susceptibility of gastric mucosa to acid-induced injury in rats by inhibiting neutrophil activation.
Harada N; Okajima K; Liu W
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S56-62. PubMed ID: 16184422
[TBL] [Abstract][Full Text] [Related]
6. Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances.
Goineau S; Castagné V
Fundam Clin Pharmacol; 2017 Apr; 31(2):155-164. PubMed ID: 27739140
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of taurine on indomethacin-induced gastric mucosal injury.
Son M; Kim HK; Kim WB; Yang J; Kim BK
Adv Exp Med Biol; 1996; 403():147-55. PubMed ID: 8915352
[TBL] [Abstract][Full Text] [Related]
8. Role of neutrophil elastase in stress-induced gastric mucosal injury in rats.
Liu W; Okajima K; Murakami K; Harada N; Isobe H; Irie T
J Lab Clin Med; 1998 Nov; 132(5):432-9. PubMed ID: 9823937
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte depletion and ONO-5046, a specific inhibitor of granulocyte elastase, prevent a stress-induced decrease in gastric prostaglandin I2 in rats.
Harada N; Okajima K; Murakami K; Uchiba M; Tanaka K; Okabe H; Takatsuki K
Biochem Biophys Res Commun; 1997 Feb; 231(1):52-5. PubMed ID: 9070218
[TBL] [Abstract][Full Text] [Related]
11. Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
Yamasaki K; Arakawa T; Takaishi O; Higuchi K; Kobayashi K; Kuroki T
Arzneimittelforschung; 1999 Apr; 49(4):359-65. PubMed ID: 10337456
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
[TBL] [Abstract][Full Text] [Related]
13. Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats.
Kokura S; Yoshikawa T; Naito Y; Ichikawa H; Takano H; Takahashi S; Tomii T; Yoshida N; Kondo M
Dig Dis Sci; 1997 Dec; 42(12):2566-71. PubMed ID: 9440637
[TBL] [Abstract][Full Text] [Related]
14. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin-induced gastric antral damage in hamsters: are neutrophils involved?
Fitzpatrick LR; Sakurai K; Le T
Aliment Pharmacol Ther; 1999 Feb; 13(2):195-202. PubMed ID: 10102950
[TBL] [Abstract][Full Text] [Related]
18. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
Sakurai K; Osaka T; Yamasaki K
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
[TBL] [Abstract][Full Text] [Related]
19. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
[TBL] [Abstract][Full Text] [Related]
20. Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation.
Murakami K; Okajima K; Harada N; Isobe H; Liu W; Johno M; Okabe H
Aliment Pharmacol Ther; 1999 Apr; 13(4):521-30. PubMed ID: 10215738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
